Application Note: Rapid SARS-CoV-2 RNA extraction from universal transport medium pooled sample mimics
3 September 2020

As demand increases for testing for SARS-CoV-2, technologies that enable pooled testing for the virus will play a critical role in the efforts to remobilize the economy. Recent analyses from public health experts estimate that pooled testing could lower testing costs by up to three-quarters and could increase testing efficiency by as much as 400%, but concerns remain about reduced test sensitivity associated with pooling. Nanotrap® Virus Particles capture and concentrate multiple strains of influenza, RSV, and coronavirus, thus enhancing detection of those viruses, even in co-infection scenarios. Here, we show that Nanotrap® Magnetic Virus Particles can capture and concentrate heat-inactivated SARS-CoV-2 from large volume universal transport medium samples that simulate patient sample pools.